Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Structural & Congenital Heart Disease: TAVR stands tall | Wait times getting longer | Boston Scientific's voluntary recall
Monday, December 7, 2020
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Structural Heart Disease

Top Stories

TAVR stands tall as ‘the dominant form of aortic valve replacement,’ specialty groups declare

Specialists from the American College of Cardiology and Society of Thoracic Surgeons explored data from more than 276,000 patients who have undergone a TAVR procedure in the last nine years. 

READ MORE >
heart.png
Share on Twitter Share on Facebook Share on Linkedin

TAVR stands tall as ‘the dominant form of aortic valve replacement,’ specialty groups declare

Share on Twitter Share on Facebook Share on Linkedin
heart.png
Specialists from the American College of Cardiology and Society of Thoracic Surgeons explored data from more than 276,000 patients who have undergone a TAVR procedure in the last nine years. 
READ MORE >

Transcatheter repair for tricuspid regurgitation is safe and effective

Transcatheter tricuspid valve repair consistently led to improved outcomes for patients with tricuspid regurgitation.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Transcatheter repair for tricuspid regurgitation is safe and effective

Share on Twitter Share on Facebook Share on Linkedin
Transcatheter tricuspid valve repair consistently led to improved outcomes for patients with tricuspid regurgitation.
READ MORE >

Wait times for TAVR, SAVR patients are getting longer and longer

The study’s authors tracked data from more than 22,000 patients with severe aortic stenosis.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Wait times for TAVR, SAVR patients are getting longer and longer

Share on Twitter Share on Facebook Share on Linkedin
The study’s authors tracked data from more than 22,000 patients with severe aortic stenosis.
READ MORE >

Aortic stenosis patients with AFib may experience more complications after valve replacement

The analysis, published in the American Journal of Cardiology, included data from more than 741,000 adult patients with aortic stenosis. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Aortic stenosis patients with AFib may experience more complications after valve replacement

Share on Twitter Share on Facebook Share on Linkedin
The analysis, published in the American Journal of Cardiology, included data from more than 741,000 adult patients with aortic stenosis. 
READ MORE >

Training for cardiothoracic surgeons may be falling short in one key area

“The association between surgeon experience and operative outcomes has been the subject of debate," the researchers explained.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Training for cardiothoracic surgeons may be falling short in one key area

Share on Twitter Share on Facebook Share on Linkedin
“The association between surgeon experience and operative outcomes has been the subject of debate," the researchers explained.
READ MORE >

Boston Scientific to retire Lotus Edge TAVR program after voluntary recall

The company will now focus its attention on the marketing and development of other solutions.

READ MORE >
business news announcement
Share on Twitter Share on Facebook Share on Linkedin

Boston Scientific to retire Lotus Edge TAVR program after voluntary recall

Share on Twitter Share on Facebook Share on Linkedin
business news announcement
The company will now focus its attention on the marketing and development of other solutions.
READ MORE >

New meta-analysis compares early TAVR outcomes for Sapien 3, Evolut valves—and spots some key differences

The new study focused on the early outcomes of more than 24,000 patients who participated in a total of nine different studies.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

New meta-analysis compares early TAVR outcomes for Sapien 3, Evolut valves—and spots some key differences

Share on Twitter Share on Facebook Share on Linkedin
The new study focused on the early outcomes of more than 24,000 patients who participated in a total of nine different studies.
READ MORE >

Among TAVR patients with AFib, DOACs lead to better survival rates than vitamin K antagonists

However, the two treatment options were associated with similar rates of long-term bleeding and ischemic events. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Among TAVR patients with AFib, DOACs lead to better survival rates than vitamin K antagonists

Share on Twitter Share on Facebook Share on Linkedin
However, the two treatment options were associated with similar rates of long-term bleeding and ischemic events. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme